Biosergen AB (publ) (STO:BIOSGN)
Sweden
· Delayed Price · Currency is SEK 10.20
+0.10 (0.99%)
Apr 29, 2026, 9:51 AM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 23.72 million as of April 28, 2026. Its market cap has decreased by -69.49% in one year.
Market Cap
23.72M
Enterprise Value
8.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.20
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 23.72M, a decrease of -88.00%. That is a compound annual growth rate of -35.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 23.48M | -74.70% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoEcho AB | 21.61M |
| Guard Therapeutics International AB | 19.44M |
| Fluicell AB | 18.34M |
| Aptahem AB | 13.00M |
| 2cureX AB | 57.49M |
| Modus Therapeutics Holding AB | 60.81M |
| ExpreS2ion Biotech Holding AB | 7.91M |
| Alzinova AB | 70.35M |